These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12390074)

  • 1. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
    Weaver AL; Gitlin N
    Arch Intern Med; 2002 Oct; 162(19):2248-9. PubMed ID: 12390074
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B;
    Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
    Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
    Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of NSAIDs induced ulcers].
    Mizokami Y; Shiraishi T; Otsubo T; Nakamura H; Miyazawa K; Narushima K; Matsuoka T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():567-71. PubMed ID: 11979847
    [No Abstract]   [Full Text] [Related]  

  • 6. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs.
    Freeman HJ
    Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of NSAID-associated gastric ulcer].
    Hiraishi H; Ota S; Terano A
    Nihon Shokakibyo Gakkai Zasshi; 2002 Jul; 99(7):760-8. PubMed ID: 12170704
    [No Abstract]   [Full Text] [Related]  

  • 9. Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
    Fernández-Fernández FJ
    Arch Intern Med; 2002 Oct; 162(19):2248. PubMed ID: 12390073
    [No Abstract]   [Full Text] [Related]  

  • 10. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastric protection and treatment with low-dose aspirin].
    Agustí-Escasany A; Vallano-Ferraz A
    Med Clin (Barc); 2006 Feb; 126(6):232-3. PubMed ID: 16510098
    [No Abstract]   [Full Text] [Related]  

  • 13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-release lansoprazole plus naproxen.
    Curran MP; Wellington K
    Drugs; 2004; 64(17):1915-9; discussion 1920-1. PubMed ID: 15329041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
    Matsukawa Y; Tomita Y; Nishinarita S; Horie T; Kato K; Arakawa Y; Ko K; Shimada H; Nakano M; Kitami Y; Kurosaka H
    J Int Med Res; 1997; 25(4):190-5. PubMed ID: 9283991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol and NSAID ulcers.
    Isaacs P
    Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
    Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
    Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
    Lanas AI
    Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
    Maiden LP; Harris AW
    N Engl J Med; 2002 Nov; 347(20):1623-4; author reply 1623-4. PubMed ID: 12432054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.